Galapagos NV
AEX:GLPG

Watchlist Manager
Galapagos NV Logo
Galapagos NV
AEX:GLPG
Watchlist
Price: 26.24 EUR 1.23% Market Closed
Market Cap: 1.7B EUR
Have any thoughts about
Galapagos NV?
Write Note

P/S
Price to Sales

3.4
Current
4.2
Median
7.5
Industry
Lower than median
Lower than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S
3.4
=
Market Cap
1.7B EUR
/
Revenue
503.8m EUR
All Countries
Close
Revenue Growth P/S to Growth
BE
Galapagos NV
AEX:GLPG
Average P/S: 3 459 765.2
3.4
-1%
N/A
FR
Pharnext SCA
OTC:PNEXF
38 055 489.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.7
6%
0.9
US
Amgen Inc
NASDAQ:AMGN
4.3
8%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
3%
1.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.9
10%
1
US
E
Epizyme Inc
F:EPE
1 851.2
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
7%
0.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.7
7%
0.8
US
S
Seagen Inc
F:SGT
17.8
30%
0.6
NL
argenx SE
XBRU:ARGX
19.4
47%
0.4

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/S
5.6
2-Years Forward
P/S
6.2
3-Years Forward
P/S
6.2

See Also

Discover More